Evidence map›Paper›PMID 30402045›Full record

ArticleContrast media & molecular imaging2018

Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience.

Stefanie J Hectors, Mathilde Wagner, Cecilia Besa, Wei Huang, Bachir Taouli

Open access · hybridAbstract read
In one paragraph

Article in Contrast media & molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. [European journal of nuclear medicine and molecular imaging · 2025
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Stefanie J HectorsTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA.ORCID 0000-0001-9457-6606
Mathilde WagnerTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA.
Cecilia BesaTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA.
Wei HuangAdvanced Imaging Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd L452, Portland, OR 97239, USA.
Bachir TaouliTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA.ORCID 0000-0001-6409-1333
Icahn School of Medicine at Mount Sinai · USOregon Health & Science University · USPontificia Universidad Católica de Chile · CLSorbonne Université · FR

Funding

Shutter-Speed Model DCE-MRI for Assessment of Response to Cancer TherapyU01CA154602 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI HUANG, WEI, RYAN, CHRISTOPHER WALTER · 2011 to 2015
$2.9M
Evaluation of HCC Response to Systemic Therapy with Quantitative MRIU01CA172320 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TAOULI, BACHIR · 2013 to 2017
$2.6M
NCI NIH HHS U01 CA154602NCI NIH HHS U01 CA172320
6 · The paper itself

Abstract

Purpose: To compare multiparametric (mp)FDG-PET/MRI metrics between hepatocellular carcinoma (HCC) and liver parenchyma and to assess the correlation between mpMRI and FDG-PET standard uptake values (SUVs) in liver parenchyma and HCC. Methods: This prospective, institutional review board-approved study enrolled 15 patients (M/F 12/3; mean age 61 y) with HCC. mpMRI including blood-oxygen-level-dependent (BOLD) MRI, intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI), and dynamic contrast-enhanced-(DCE-) MRI was performed simultaneously with Results: 21 HCC lesions (mean size 4.0 ± 2.4 cm; range 2-13 cm) were analyzed. HCCs exhibited significantly higher arterial fraction (from DCE-MRI) and lower Conclusions: Despite the observed reasonable diagnostic performance of FDG-PET SUV

Indexed as

AgedCarcinoma, HepatocellularFemaleFluorodeoxyglucose F18HumansLiverLiver NeoplasmsMagnetic Resonance ImagingMaleMiddle AgedMultimodal ImagingParenchymal TissuePilot ProjectsPositron-Emission TomographyProspective StudiesFluorodeoxyglucose F18

Identifiers

PMID30402045
PMCPMC6192124
OpenAlexW2895463391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.